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areas of good practice have been identified. The data presented here
map the current and proposed areas of good practice against the
Gold Standards Framework (GSF)1 which has been adopted as a
building block towards cohesive palliative care service provision.
Methods The 2008 national audit of hospital COPD care included a
survey of resources and organisation of care within which was a free
text box to describe current examples of good practice and proposed
service developments. These elements were mapped against the
seven key standards from the GSF. All 184 acute trusts admitting
COPD exacerbations from the four countries of the UK were
included in the survey during the spring of 2008.
Results 180 NHS acute trusts (98% of those eligible) comprising 239
hospital units completed the survey. Mapping the examples of
practice identified against the seven key GSF standards revealed
current and proposed service development is focused on three
standards alone while others are neglected. The following stan-
dards—control of symptoms (eg, guideline development and
advance care planning), care in the dying phase (eg, use of the
Liverpool care pathway) and continued learning (eg, COPD teams
learning palliative care skills) were identified as areas of develop-
ment, both current and proposed. Other standards such as
communication, co-ordination, support for carers and continuity
of care including out-of-hours and advance planning for reduction
in crisis admissions have, to date, been overlooked.
Conclusions Palliative care service provision for COPD patients
remains in its infancy with current service development predomi-
nantly focusing on three of the seven key standards recommended
in the GSF. If a successful holistic palliative care service is to be
provided, those involved in COPD end-of-life care need to widen the
scope of their current thinking.
1. Thomas K, Department of Health. Gold Standards Framework: a programme for
community palliative care. 2005. www.goldstandardsframework.nhs.uk.
P49 COPD CASE-FINDING PILOT EVALUATION: ‘‘FINDING OUR
MISSING THOUSANDS’’
L Chandler, H Laird, L Wheater, E Smith, SPL Meghjee. NHS Wakefield District,
Wakefield, UK
doi:10.1136/thx.2009.127134w
Aim Early detection of chronic obstructive pulmonary disease
(COPD) is critical in order to reduce the burden of disease on the
individual and to reduce costs on the wider health economy.
However, patients often present late in the disease process. The use
of screening spirometry for symptomatic patients in community
health settings has been proposed as a mechanism for increasing
access to advice and information and the earlier identification of
COPD in a wider population. This pilot aimed to evaluate the use of
a screening tool and screening spirometer in community settings to
support case finding of symptomatic COPD patients.
Methods Five GP practices, five pharmacies and the NHS Quit Shop
acted as recruitment sites. Patients who presented at the sites were
recruited to the pilot and asked to complete a screening questionnaire.
Patients who met selection criteria completed screening spirometry.
All patients were given information and those with abnormal results
referred to their GP. Patient satisfaction questionnaires were sent to
all service users and a focus group held for pilot sites.
Results 377 people underwent assessment, 106 (28.2%) were referred
for diagnostic spirometry and 59 (55.7%) attended their GP practices.
There was a significant difference between the number of patients
that were screened at each setting (p = 0.007), with the Quit Shop
screening a higher proportion of patients (40.6%) than GPs (27.6%)
and pharmacies (31.8%). No significant difference between the
proportions of diagnoses across the three settings was found
(p = 0.88). 32 people (53.3%) were diagnosed with COPD, 5 (8.3%)
with asthma, 7 (11.7%) with ‘‘other’’ problems and in 16 (26.7%) no
problem was identified. Staff and patient satisfaction surveys were
positive. Staff suggested that the service should continue alongside
stop smoking services in all settings and should be linked with
cardiovascular disease risk assessments.
Conclusions Overall the pilot appears to have been successful in raising
awareness of COPD in local communities. There remain concerns
regarding the number of false positives and the number of patients
who did not go on to attend diagnostic spirometry with their GP
practice. Further work is required to decide whether the service will be
commissioned as an ‘‘add on’’ to services already commissioned.
P50 SMOKING PREVALENCE AND ATTITUDES IN MEDICAL
INPATIENTS IN LIVERPOOL
1S Huq, 1MI Hasan, 1A Nwosu, 1J Hadcroft, 2M Walshaw. 1Royal Liverpool University
Hospital, Liverpool, UK; 2Liverpool Heart and Chest Hospital, Liverpool, UK
doi:10.1136/thx.2009.127134x
Introduction Liverpool has a high incidence of smoking-related illness
and higher rates of smokers than the rest of the UK. The ‘‘SmokeFree
Liverpool’’ campaign run by the City Council aims to reduce smoking
among the population. However, ill patients may have a different
perspective. To study this, we compared attitudes towards smoking
in medical inpatients with the results of the 2008 ‘‘SmokeFree
Liverpool’’ survey for the general population of Liverpool.
Methods A prospective cross-sectional survey of 100 consecutive
inpatients (mean¡SD age 61¡15.5 years, 49 men) on general
medical wards at the Royal Liverpool University Hospital (an 850-
bed facility serving the city of Liverpool) who were able to respond
to our questionnaire. Data related to smoking status, smoking
behaviour in household and cars, intention to stop and support for
current and possible future smoke-free legislation were gathered.
Results Smoking prevalence was higher in medical patients
compared with the general population (39% vs 29%) and they
were more likely to smoke inside housing (36% vs 27%) and vehicles
(12% vs 5%). Inpatient smokers were predominantly male (51%
male and 27% female patients were smokers) and in the 25–64-year
age group. More smokers in hospital declared their intention to stop
(79% vs 55%) and the majority (54% vs 13%) were hopeful of
stopping within a month. Support for the 2007 smoke-free
legislation was higher among the hospitalised smokers (69% vs
57%). 91% of respondents (95% of smokers) supported future
legislation imposing a ban on smoking inside cars with children.
Regarding quitting, 67% of inpatient current smokers had received
medical advice and 85% had unsuccessful prior attempts (60% used
some form of pharmacotherapy).
Conclusion This survey demonstrates that the prevalence of smoking
in Liverpool is higher in hospitalised patients, particularly in men.
However, although these individuals expressed a stronger intention
to quit than the normal population, they had found this hard to
carry out. This indicates that the targeting of antismoking resources
to the hospital sector may produce a better yield in helping patients
to quit this potentially lethal habit.
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London School of Medicine, Queen Mary, University of London, London, UK
doi:10.1136/thx.2009.127134y
Introduction Trials of self-management (SM) interventions for
chronic obstructive pulmonary disease (COPD) have often had
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disappointing results. A recent Cochrane review suggested SM may
reduce hospital admissions but concluded data are still insufficient
to formulate recommendations.1
Objectives To conduct a pilot randomised controlled trial of a new
disease-specific self-management programme for COPD.
Methods The intervention was based on the UK Expert Patients
Programme (EPP) which is underpinned by the sociocognitive self-
efficacy theory.2 It was distinct in three ways: (1) COPD relevant
content; (2) sessions delivered by a trained lay tutor with COPD
who ‘‘models’’ good SM; (3) involvement of a respiratory clinician
(COPD patients have significant information needs). It involved
seven weekly 2.5 h group sessions. Patients were recruited from
primary care disease registers and randomised (2:1) to intervention
or usual care. The St George Respiratory Questionnaire (SGRQ),
Hospital Anxiety and Depression Scale (HADS), EQ-5D, exercise
levels and self-efficacy (confidence) to manage COPD were collected
at baseline, 2 and 6 months, as were all costs and healthcare
resource use.
Results 224 (44%) patients replied to invitation letters and 116
(22%) were enrolled and randomised (78 intervention; 38
control). 46% were male, mean¡SD age 69.5¡9.8 years, mean
forced expiratory volume in 1 s (FEV1)% predicted 54%, 78% had
had unscheduled COPD care in the previous 12 months. Groups
were roughly similar at baseline. 35% of intervention patients
did not attend any course sessions, 40% attended 5 or more
sessions. The results at 6 months suggest that the intervention
may increase exercise levels by a modest amount and increase
health-related quality of life as measured by the EQ-5D (no
overall effect on Total SGRQ score was detected) (table 1).
Economic analyses suggested that, with a willingness to pay
threshold of £10 000 per quality adjusted life year gained
(QALY), the intervention would have a 70% probability of
being cost effective.
Conclusions The intervention may be unappealing or inaccessible to
many patients. Despite this, the pilot study suggests the interven-
tion may improve quality of life and is likely to meet NICE criteria
for a cost-effective intervention.
1. Effing, 2007.
2. Bandura, 1977.
P52 RANDOMISED CONTROLLED TRIAL OF A SELF-MANAGEMENT
PROGRAMME OF ACTIVITY, COPING AND EDUCATION (SPACE)
FOR COPD
1LD Apps, 2K Wagg, 2L Sewell, 2J Williams, 1SJ Singh, 2SJ Singh. 1Coventry
University, Coventry, UK; 2University Hospitals of Leicester, Leicester, UK
doi:10.1136/thx.2009.127134z
Self-management programmes in chronic obstructive pulmonary
disease (COPD) have been explored with some positive results.
However, the recent Cochrane Review (2007) concluded that, while
there is some evidence for self-management education, further
research was required to provide clear guidelines about its use. This
study is a randomised controlled trial conducted in primary care to
determine the effectiveness of a stand alone self-management manual
for COPD (SPACE for COPD, A Self-management Programme of
Activity, Coping & Education) compared with usual care.
Participants were recruited from primary care registers and
randomised to usual care or self-management. The primary outcome
measure was health status (Self-Reported Chronic Respiratory
Questionnaire (CRQ-SR)) measured at baseline and 6 weeks.
Exercise performance (Incremental Shuttle Walking Test (ISWT)
and Endurance Shuttle Walk Test (ESWT)) was recorded as well as
scores on the Hospital Anxiety and Depression Scale (HADS).
To date, 36 patients have completed measures at 6 weeks, 19 from
usual care (mean (SD) age 71.21 (9.17) years; forced expiratory volume
in 1 s (FEV1) 1.45 (0.49) l; 12 men) and 17 from self-management
(mean (SD) age 65.41 (10.16) years; FEV1 1.53 (0.62) l; 8 men). Paired t
tests were performed and the results are shown in table 1 for all
outcome measures. There were statistically significant improvements
in the self-management group for CRQ-SR domain of dyspnoea with a
mean change of 0.74. There were no significant changes in the
standard care group in all CRQ-SR domains of dyspnoea, fatigue,
emotion and mastery. Mean changes were 0.41, 0.16, 0.23 and 0.10,
respectively. Statistically significant between-group differences were
found for ISWT (p,0.01), ESWT (p,0.001), CRQ emotion domain
and anxiety (p,0.05). In addition, the CRQ domain of emotion
attained the minimal clinically important threshold of .0.5.
Abstract P51 Table 1 Outcomes at baseline and 6 months and differences between intervention and control
groups at 6 months (available case analysis)
Control (n = 30) Intervention (n = 61)
*Estimated
difference (95% CI)
Direction of
effect favoursBaseline 6 months Baseline 6 months
SGRQ
Symptoms 58.0 50.4 54.9 52.5 4.7 (23.0 to 12.4) Control
Activities 57.3 58.7 55.5 53.0 24.8 (211.3 to 1.8) Intervention
Impacts 34.4 31.8 36.6 33.9 20.3 (25.1 to 5.7) Intervention
Total score 45.3 43.1 45.4 42.8 20.4 (25.1 to 4.4) Intervention
Strengthening exercise (min/
week)
22.0 9.0 22.6 21.6 12.4 (23.8 to 28.6) Intervention
Aerobic exercise (min/week) 56.0 43.5 65.7 59.1 10.1 (216.3 to 35.5) Intervention
Self-efficacy to communicate
with doctors
8.0 7.7 8.5 8.2 0.2 (20.6 to 1.1) Intervention
Self-efficacy to manage
disease
7.4 7.8 7.6 7.4 20.5 (21.0 to 0.1) Control
HADS
Anxiety 6.7 6.7 6.1 5.7 20.5 (21.8 to 0.9) Intervention
Depression 4.8 5.1 5.4 5.7 0.2 (20.8 to 1.3) Control
EQ-5D 0.76 0.57 0.73 0.68 0.12 (20.02 to 0.26) Intervention
*Using ANCOVA, regression coefficient of intervention versus control.
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This shows that it is feasible to deliver a self-management
package in primary care as a stand alone manual, with significant
improvements demonstrated in dyspnoea, exercise performance and
anxiety.
P53 PULMONARY REHABILITATION USING THE SPACE (A SELF-
MANAGEMENT PROGRAMME OF ACTIVITY, COPING AND
EDUCATION) MANUAL AT HOME: A RANDOMISED
CONTROLLED TRIAL
1K Wagg, 2E Wilcock, 1J Williams, 1L Sewell, 1M Steiner, 1M Morgan, 2S Singh.
1University Hospitals Leicester, Leicester, UK; 2Coventry University, Coventry, UK
doi:10.1136/thx.2009.127142a
Pulmonary rehabilitation is an established intervention for patients
with chronic obstructive pulmonary disease (COPD), however
capacity across the UK is low. The traditional model of rehabilita-
tion is 6–8 weeks of supervised exercise and education. We have
developed a self-management manual for COPD (SPACE: A Self-
management Programme of Activity, Coping and Education). If a
self-managed pulmonary rehabilitation programme is effective,
alternative forms of pulmonary rehabilitation may become more
widely available. The aim of this study is to determine the
effectiveness of a self-management programme against conven-
tional rehabilitation.
Participants with COPD were recruited following a standard
pulmonary rehabilitation assessment and randomly allocated to
either a 7-week conventional rehabilitation course or self-managed
rehabilitation using the SPACE manual. The primary outcome
measure was peak exercise performance (Incremental Shuttle
Walking Test (ISWT)) measured at initial assessment and 7 weeks.
Other outcome measures were Endurance Shuttle Walk Test
(ESWT), Self-Reported Chronic Respiratory Questionnaire (CRQ-
SR) Dyspnoea Domain and the Medical Research Council
Dyspnoea Scale (MRC). 62 patients were recruited and allocated
to conventional rehabilitation (n = 29; mean (SD) age 67.93 (7.47);
forced expiratory volume in 1 s (FEV1) 1.38 (0.52); body mass index
(BMI) 26.27 (5.91); 18 men) or self-management (n = 33; mean (SD)
age 66.75 (8.00); FEV1 1.16 (0.36); BMI 26.77 (5.76); 2 men).
Patients were re-assessed at 7 weeks and paired t tests were
performed for all outcome measures.
There were statistically significant improvements for both
conventional rehabilitation and self-managed rehabilitation in
ISWT with mean changes of 54.48¡89.06 and 40.30¡70.02,
respectively. There were also statistically significant improvements
for ESWT, CRQ-SR Dyspnoea and MRC in both groups; mean
changes in conventional rehabilitation being 500.62, 0.64 and 0.80,
respectively, and in self-managed rehabilitation being 331.33, 0.77
and 0.71, respectively (table 1). There were no statistically
significant between-group differences found in ISWT, ESWT,
CRQ Dyspnoea and MRC (p.0.05).
Participants who completed both conventional rehabilitation and
a self-management programme showed significant improvements in
exercise performance and perceived dyspnoea. There were no
significant differences between the outcomes for each group. This
shows that a self-managed rehabilitation programme is an effective
alternative to conventional rehabilitation.
P54 COPD PATIENTS’ BELIEFS AND EXPECTATIONS OF
PULMONARY REHABILITATION
1J O’Connor, 1T Cartwright, 2C Lee, 2L Nabarro, 1P Evans, 1A Clow, 1D Peters,
2SL Elkin. 1Department of Psychology, University of Westminster, London, UK;
2Imperial College Healthcare NHS Trust, London, UK
doi:10.1136/thx.2009.127142b
Introduction The effectiveness of pulmonary rehabilitation (PR) for
chronic obstructive pulmonary disease (COPD) is tempered by the
effect of time. Little is known about the role of patients’ beliefs and
expectations in outcome response and in maintenance. The aim of
Abstract P52 Table 1 Mean baseline scores and mean changes for Hospital Anxiety and Depression Scale,
Self-Reported Chronic Respiratory Questionnaire, Incremental Shuttle Walking Test (ISWT) and Endurance
Shuttle Walk Test (ESWT) for usual care and self-management groups
Measure
Self-management Usual GP care
Baseline Mean change (95% CI) Baseline Mean change (95% CI)
Anxiety 7.41 21.76 (20.10 to 3.23)* 4.74 0.84 (2.55 to 0.87)
Depression 4.88 20.35 (0.91 to 3.43) 3.95 0.53 (1.37 to 0.31)
Dyspnoea 3.31 0.74 (1.23 to 0.25)** 3.25 0.41 (0.87 to 0.04)
Fatigue 4.13 0.34 (0.97 to 0.29) 4.60 0.16 (0.40 to 0.72)
Emotion 4.84 0.51 (1.05 to 0.03) 5.22 0.23 (0.08 to 0.53)
Mastery 5.48 0.30 (0.81 to 0.22) 5.62 0.10 (0.24 to 0.44)
ISWT (m) 325.29 37.65 (70.44 to 4.85)* 342.63 228.42 (22.60 to 54.24)*
ESWT (s) 227.00 358.59 (506.65 to 210.52)*** 369.95 34.53 (98.32 to 29.27)
*.0.05; **.0.01; ***.0.001 within subjects.
Abstract P53 Table 1 Mean baseline and mean changes for Incremental Shuttle Walking Test (ISWT),
Endurance Shuttle Walk Test (ESWT), Chronic Respiratory Questionnaire Self-Reported (CRQ-SR) Dyspnoea
Domain and MRC for conventional rehabilitation and self-management groups
Measure
Conventional rehabilitation Self-management
Baseline Mean change (95% CI) Baseline Mean change (95% CI)
ISWT 277.24 54.43 (88.36 to 20.60)* 253.33 40.30 (65.13 to 15.47)*
ESWT 225.00 500.62 (656.90 to 344.32)** 257.02 331.33 (483.86 to 178.81)**
CRQ-SR Dyspnoea 2.61 0.64 (1.11 to 1.72)* 2.14 0.77 (1.19 to 0.34)*
MRC 3.40 20.80 (20.48 to 1.12)** 3.19 20.71 (20.35 to 0.07)**
*.0.01; **.0.001.
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